Reactive oxygen and reactive nitrogen as signaling molecules for caspase 3 activation in acute cardiac transplant

Galen M Pieper1, Vani Nilakantan, Thanh K Nguyen

  • 1Division of Transplant Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA. gmpieper@mcw.edu

Insights

This study reveals that both superoxide and nitric oxide (NO) contribute to caspase 3 activation, a key process in cardiac allograft rejection and graft failure. Targeting these molecules may offer new therapeutic strategies for preventing heart transplant rejection.

Area of Science:

  • Cardiology
  • Immunology
  • Biochemistry

Background:

  • Cardiac allograft rejection is a major cause of graft failure.
  • Apoptosis, mediated by caspase 3 activation, plays a critical role in this process.
  • Understanding the upstream signaling molecules is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the roles of reactive oxygen species (ROS) and nitric oxide (NO) in caspase 3 activation during acute cardiac allograft rejection.
  • To evaluate the effects of various therapeutic agents on these signaling pathways.

Main Methods:

  • Utilized a model of acute cardiac allograft rejection.
  • Measured superoxide radical production, Western blotting for cleaved caspase 3, and direct caspase 3 activity assays.
  • Administered treatments including cyclosporine (CsA), PBN, vitamin C, MnTmPyP, and L-NIL.

Main Results:

  • Caspase 3 activation was observed in untreated allografts.
  • Cyclosporine (CsA) and PBN inhibited inducible NO synthase (iNOS) expression and caspase 3 activity.
  • Vitamin C and MnTmPyP inhibited caspase 3 activity without affecting iNOS or NO levels.
  • L-NIL inhibited NO production and caspase 3 activity, with MnTmPyP and L-NIL preventing apoptosis.

Conclusions:

  • Both superoxide and NO are significant contributors to caspase 3 activation in cardiac allograft rejection.
  • These molecules act as precursors to peroxynitrite formation, driving apoptosis.
  • Findings suggest potential therapeutic targets for mitigating cardiac transplant rejection.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.